CoChat

The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors

Riga, Maurizio S., Lladó-Pelfort, Laia, Artigas, Francesc, Celada, Pau · 2018 · Neuropharmacology
Cited by 53

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

&NA; 5‐MeO‐DMT is a natural hallucinogen acting as serotonin 5‐HT1A/5‐HT2A receptor agonist. Its ability to evoke hallucinations could be used to study the neurobiology of psychotic symptoms and to identify new treatment targets. Moreover, recent studies revealed the therapeutic potential of serotonin hallucinogens in treating mood and anxiety disorders. Our previous results in anesthetized animals show that 5‐MeO‐DMT alters cortical activity via 5‐HT1A and 5‐HT2A receptors. Here, we examined 5‐MeO‐DMT effects on oscillatory activity in prefrontal (PFC) and visual (V1) cortices, and in mediodorsal thalamus (MD) of freely‐moving wild‐type (WT) and 5‐HT2A‐R knockout (KO2A) mice. We performed local field potential multi‐recordings evaluating the power at different frequency bands and coherence between areas. We also examined the prevention of 5‐MeO‐DMT effects by the 5‐HT1A‐R antagonist WAY‐100635. 5‐MeO‐DMT affected oscillatory activity more in cortical than in thalamic areas. More marked effects were observed in delta power in V1 of KO2A mice. 5‐MeO‐DMT increased beta band coherence between all examined areas. In KO2A mice, WAY100635 prevented most of 5‐MeO‐DMT effects on oscillatory activity. The present results indicate that hallucinatory activity of 5‐MeO‐DMT is likely mediated by simultaneous alteration of prefrontal and visual activities. The prevention of these effects by WAY‐100635 in KO2A mice supports the potential usefulness of 5‐HT1A receptor antagonists to treat visual hallucinations. 5‐MeO‐DMT effects on PFC theta activity and cortico‐thalamic coherence may be related to its antidepressant activity. This article is part of the Special Issue entitled ‘Psychedelics: New Doors, Altered Perceptions’. Hightlights5‐MeO‐DMT alters cortico‐thalamic activity more in mPFC and V1 than MD thalamus.5‐MeO‐DMT augments beta band coherence between cortico‐thalamic areas.5‐HT1A‐R antagonism avoids 5‐MeO‐DMT actions in KO2A mice.Increase in PFC theta band by 5‐MeO‐DMT may be related to its antidepressant effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2017.11.049

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 53

Metadata

Authors
Riga, M. S., Lladó-Pelfort, L., Artigas, F., & Celada, P.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2018-11
Volume
142
Pages
219-230
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2773072410
Cited by
53
References
31
FWCI
3.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. https://app.cochat.ai/papers/10.1016/j.neuropharm.2017.11.049
The paper
Riga, M. S., Lladó-Pelfort, L., Artigas, F., & Celada, P. (2018). The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2017.11.049

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.